The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variant
emerged in November 2021 and consists of several mutations within the spike. We use …

The novel SARS-CoV-2 variant, Omicron (B. 1.1. 529) contains about 30 mutations in the
spike protein and the numerous mutations raise the concern of escape from vaccine …

Vaccines based on the spike protein of SARS-CoV-2 are a cornerstone of the public health
response to COVID-19. The emergence of hypermutated, increasingly transmissible variants …

Due to numerous mutations in the spike protein, the SARS-CoV-2 variant of concern
Omicron (B. 1.1. 529) raises serious concerns since it may significantly limit the antibody …

Background The immune profile against severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has dramatically diversified due to a complex combination of exposure to …

The Omicron (B. 1.1. 529) SARS-CoV-2 variant contains an unusually high number of
mutations in the spike protein, raising concerns of escape from vaccines, convalescent …

Abstract The SARS-CoV-2 B. 1.617 lineage was identified in October 2020 in India,,,–. Since
then, it has become dominant in some regions of India and in the UK, and has spread to …

The emergence of highly mutated severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) variant Omicron (B. 1.1. 529) has ushered panic responses around the world due to …

Since its emergence at the end of 2019, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has caused the infection of more than 600 million people worldwide and has …

Recently a new variant of SARS-CoV-2 was reported from South Africa. World Health
Organization (WHO) named this mutant as a variant of concern–Omicron (B. 1.1. 529) on …